✦ LIBER ✦
717 ORAL Gemcitabine (GEM) plus capecitabine (CAP) versus GEM alone in locally advanced or metastatic pancreatic cancer. aspects of quality of life in a randomized phase III study of the Swiss Group for Clinical Cancer Research (SAKK) and the Central European Cooperative Oncology Group (CECOG)
- Book ID
- 118623293
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 261 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.